Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

CXCR receptor antagonists in development at SB for chemokine-mediated disorders

April 23, 1999

TP-508 promotes the wound-healing process via a novel mechanism

April 22, 1999

Shiseido provides methods of promoting hair regrowth

April 22, 1999

Cell proliferation induction (CPI): a novel approach to wound healing

April 21, 1999

Bioglan and Allergan form psoriasis therapy partnership

April 20, 1999

Xoma and Genentech extend hu1124 agreement; present preliminary results from psoriasis trial

April 20, 1999

News from FASEB: dermal pharmacology of Dekk-Tec's A-007

April 19, 1999

E.U.-wide approval obtained for Regranex

April 14, 1999

Production method and structure of all-trans-retinol metabolite disclosed by WARF

April 14, 1999

U.S. patent issued to Procyon for scar prevention therapy

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...